SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells

被引：0
|
作者：
Nicole C Dubois
April M Craft
Parveen Sharma
David A Elliott
Edouard G Stanley
Andrew G Elefanty
Anthony Gramolini
Gordon Keller
机构：
[1] McEwen Centre for Regenerative Medicine,Department of Physiology
[2] Ontario Cancer Institute,undefined
[3] University Health Network,undefined
[4] University of Toronto,undefined
[5] Monash Immunology and Stem Cell Laboratories,undefined
[6] Monash University,undefined
来源：
Nature Biotechnology | 2011年 / 29卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Cardiomyocytes generated from human pluripotent stem cells have many potential applications in drug screening, disease modeling and cell therapy. Dubois et al. describe a cell-surface marker that allows the isolation of highly enriched populations of cardiomyocytes from differentiation cultures.
引用
下载
收藏
页码：1011 / 1018
页数：7
相关论文
共 50 条
  • [31] Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes
    Giacomelli, E.
    Mummery, C. L.
    Bellin, M.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2017, 74 (20) : 3711 - 3739
  • [32] Component Currents of Cardiac Human Cardiomyocytes Derived from Induced Pluripotent Stem Cells
    Lis, Agniezka
    Cimato, Thomas J.
    Bett, Glenna C. L.
    Rasmusson, Randall L.
    Morales, Michael J.
    BIOPHYSICAL JOURNAL, 2012, 102 (03) : 674A - 674A
  • [33] Modeling hypertrophic cardiomyopathy with human cardiomyocytes derived from induced pluripotent stem cells
    Jiangtao Li
    Xin Feng
    Xiang Wei
    Stem Cell Research & Therapy, 13
  • [34] Maturation of Cardiomyocytes Derived from Human Pluripotent Stem Cells: Current Strategies and Limitations
    Jiang, Yanqing
    Park, Peter
    Hong, Sang-Min
    Ban, Kiwon
    MOLECULES AND CELLS, 2018, 41 (07) : 613 - 621
  • [35] Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes
    E. Giacomelli
    C. L. Mummery
    M. Bellin
    Cellular and Molecular Life Sciences, 2017, 74 : 3711 - 3739
  • [36] Generating Injectable Vascularized Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
    Aoyama, Junya
    Sokol, Morgan
    Zhu, Anthony
    Cao, Fang
    Gil, Eun S.
    Aleksi, Elton
    Garbern, Jessica
    Elwell, Hannah
    Barrera, Irving
    Lee, Richard T.
    CIRCULATION RESEARCH, 2023, 133
  • [37] Cardiomyocytes derived from human embryonic and induced pluripotent stem cells: comparative ultrastructure
    Gherghiceanu, Mihaela
    Barad, Lili
    Novak, Atara
    Reiter, Irina
    Itskovitz-Eldor, Joseph
    Binah, Ofer
    Popescu, L. M.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2011, 15 (11) : 2539 - 2551
  • [38] Current Strategies and Challenges for Purification of Cardiomyocytes Derived from Human Pluripotent Stem Cells
    Ban, Kiwon
    Bae, Seongho
    Yoon, Young-sup
    THERANOSTICS, 2017, 7 (07): : 2067 - 2077
  • [39] The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells
    Yokoo, Noritaka
    Baba, Shiro
    Kaichi, Shinji
    Niwa, Akira
    Mima, Takahiro
    Doi, Hiraku
    Yamanaka, Shinya
    Nakahata, Tatsutoshi
    Heike, Toshio
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 387 (03) : 482 - 488
  • [40] Doxorubicin-induced toxicity in cardiomyocytes derived from human pluripotent stem cells
    Holmgren, Gustav
    Synnergren, Jane
    Bogestal, Yalda
    Ameen, Caroline
    Akesson, Karolina
    Holmgren, Sandra
    Lindahl, Anders
    Sartipy, Peter
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2015, 75 : 195 - 195
12345